Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Endocrinology and Metabolism ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.N Engl J Med. 2017; 376: 1407-1418
- Dyslipidemia Management in Adults With Diabetes.Can J Diabetes. 2020; 44: 53-60
- Metabolic Dyslipidemia and Risk of Coronary Heart Disease in 28,318 Adults With Diabetes Mellitus and Low-Density Lipoprotein Cholesterol <100 mg/dl.Am J Cardiol. 2015; 116: 1700-1704
- Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23).BMJ. 1998; 316: 823-828
- Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.Lancet Lond Engl. 2004; 364: 685-696
- Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.Lancet Lond Engl. 2008; 371: 117-125
- Efficacy of Standard and Intensive Statin Treatment for the Secondary Prevention of Cardiovascular and Cerebrovascular Events in Diabetes Patients: A Meta-Analysis.PLOS ONE. 2014; 9: e111247
- Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2022.Diabetes Care. 2021; 45: S144-S174
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol.J Am Coll Cardiol. 2019; 73: e285-e350
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.N Engl J Med. 2015; 372: 2387-2397
- Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial.Lancet Diabetes Endocrinol. 2017; 5: 941-950
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.N Engl J Med. 2019; 380: 11-22
- Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.JAMA. 2020; 324: 2268-2280
- Diabetes and Hypertension: A Position Statement by the American Diabetes Association.Diabetes Care. 2017; 40: 1273-1284
- Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes.BMJ. 1998; 317: 703-713
- The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus.N Engl J Med. 2010; 362: 1575-1585
- Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses.BMJ. 2016; 352: i717
- Primary Prevention of Cardiovascular Disease in Diabetes Mellitus.J Am Coll Cardiol. 2017; 70: 883-893
- Standards of Medical Care in Diabetes—2016 Abridged for Primary Care Providers.Clin Diabetes Publ Am Diabetes Assoc. 2016; 34: 3-21
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes.Lancet. 1998; 352: 837-853
- Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.BMJ. 2000; 321: 405-412
- Intensive glycemic control and cardiovascular disease: an update.Nat Rev Cardiol. 2010; 7: 369-375
- Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes.N Engl J Med. 2009; 360: 129-139
- The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of Intensive Glucose Lowering in Type 2 Diabetes.N Engl J Med. 2008; 358: 2545-2559
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes.N Engl J Med. 2008; 358: 2560-2572
- Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: A Meta-analysis.JAMA Cardiol. 2021; 6: 148-158
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.Lancet Diabetes Endocrinol. 2019; 7: 776-785
- Beneficial impact of spironolactone in diabetic nephropathy.Kidney Int. 2005; 68: 2829-2836
- Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.N Engl J Med. 2020; 383: 2219-2229
- Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.N Engl J Med. 2021; 385: 2252-2263
- Finerenone: First Approval.Drugs. 2021; 81: 1787-1794
- Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes.N Engl J Med. 2018; 379: 633-644
- Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus.N Engl J Med. 2018; 379: 1529-1539
- Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.N Engl J Med. 2017; 377: 1319-1330
- Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes.Cardiovasc Diabetol. 2021; 20: 220
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.N Engl J Med. 2017; 377: 1119-1131
- Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.N Engl J Med. 2019; 381: 2497-2505
- Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes.N Engl J Med. 2013; 369: 145-154
- Academy of Nutrition and Dietetics Nutrition Practice Guideline for Type 1 and Type 2 Diabetes in Adults: Systematic Review of Evidence for Medical Nutrition Therapy Effectiveness and Recommendations for Integration into the Nutrition Care Process.J Acad Nutr Diet. 2017; 117: 1659-1679
- Lifestyle weight-loss intervention outcomes in overweight and obese adults with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials.J Acad Nutr Diet. 2015; 115: 1447-1463
- Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.N Engl J Med. 2018; 378: e34
- Effects of the Dietary Approach to Stop Hypertension (DASH) diet on cardiovascular risk factors: a systematic review and meta-analysis.Br J Nutr. 2015; 113: 1-15
- 5. Facilitating Behavior Change and Well-being to Improve Health Outcomes: Standards of Medical Care in Diabetes—2022.Diabetes Care. 2021; 45: S60-S82
- Relationship between sleep disturbance and self-care in adults with type 2 diabetes.Acta Diabetol. 2018; 55: 963-970
- Sleep Duration and Risk of Type 2 Diabetes: A Meta-analysis of Prospective Studies.Diabetes Care. 2015; 38: 529-537
- 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes-2022. - Abstract - Europe PMC.(Available at:) (Accessed July 1, 2022)
- Varenicline in smokers with diabetes: A pooled analysis of 15 randomized, placebo-controlled studies of varenicline.J Diabetes Investig. 2017; 8: 93-100
- Social Determinants of Health and Diabetes: A Scientific Review.Diabetes Care. 2020; 44: 258-279
- Socioeconomic position and first-time major cardiovascular event in patients with type 2 diabetes: a Danish nationwide cohort study.Eur J Prev Cardiol. 2022; 28: 1819-1828
- Health-Literacy-Sensitive Diabetes Self-Management Interventions: A Systematic Review and Meta-Analysis.Worldviews Evid Based Nurs. 2016; 13: 324-333
- Community Health Worker Interventions to Improve Glycemic Control in People with Diabetes: A Systematic Review and Meta-Analysis.J Gen Intern Med. 2015; 30: 1004-1012
- The health benefits of the great outdoors: A systematic review and meta-analysis of greenspace exposure and health outcomes.Environ Res. 2018; 166: 628-637
- Effects of Home Particulate Air Filtration on Blood Pressure.Hypertension. 2020; 76: 44-50https://doi.org/10.1161/HYPERTENSIONAHA.119.14456
- Impact of Reductions in Emissions from Major Source Sectors on Fine Particulate Matter-Related Cardiovascular Mortality.Environ Health Perspect. 2020; 128: 17005
- Cardiovascular Risk Heterogeneity in Adults with Diabetes: Selective Use of Coronary Artery Calcium in Statin Use Decision-making.J Gen Intern Med. 2019; 34: 2643-2647
- Coronary Artery Calcium Score for Long-term Risk Classification in Individuals With Type 2 Diabetes and Metabolic Syndrome From the Multi-Ethnic Study of Atherosclerosis.JAMA Cardiol. 2017; 2: 1332-1340
- Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables.Lancet Diabetes Endocrinol. 2018; 6: 361-369
- Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes.Diabetes Care. 2021; 44: 2438-2444
- Association of type 2 diabetes remission and risk of cardiovascular disease in pre-defined subgroups.Endocrinol Diabetes Metab. 2021; 4: e00280
Article info
Publication history
Published online: November 17, 2022
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
